Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $155M (100.0% shares, 0.0% debt)

Holdings (32)

GLPG GALAPAGOS NV 15.0%

Value $23.2M Shares 374,000 Est. Cost $58.55 Unrealized —

PRTA PROTHENA CORP PLC 13.4%

Value $20.72M Shares 566,538 Est. Cost $26.31 Unrealized +37.0%

— ALBIREO PHARMA INC 9.2%

Value $14.32M Shares 480,000 Est. Cost $30.59 Unrealized —

— GALAPAGOS NV 7.8%

Value $12.09M Shares 195,000 Est. Cost — Unrealized —

CRL CHARLES RIV LABS INTL INC 5.8%

Value $8.945M Shares 31,500 Est. Cost $347.75 Unrealized -11.3%

KALV KALVISTA PHARMACEUTICALS INC 5.6%

Value $8.686M Shares 589,270 Est. Cost $19.16 Unrealized -25.0%

CUE CUE BIOPHARMA INC 4.8%

Value $7.37M Shares 1,510,282 Est. Cost $11.54 Unrealized -38.7%

ALDX ALDEYRA THERAPEUTICS INC 4.0%

Value $6.224M Shares 1,400,239 Est. Cost $7.18 Unrealized -44.5%

MGTX MEIRAGTX HLDGS PLC 3.4%

Value $5.273M Shares 380,700 Est. Cost $15.40 Unrealized 0.0%

— KEZAR LIFE SCIENCES INC 3.2%

Value $4.986M Shares 300,000 Est. Cost $5.82 Unrealized —

— CONVEY HEALTH SOLUTIONS HLDG 3.2%

Value $4.893M Shares 748,134 Est. Cost $9.97 Unrealized —

ALNY ALNYLAM PHARMACEUTICALS INC 2.4%

Value $3.707M Shares 22,704 Est. Cost $185.86 Unrealized -18.0%

AGL AGILON HEALTH INC 2.3%

Value $3.549M Shares 140,000 Est. Cost $31.52 Unrealized -34.6%

STTK SHATTUCK LABS INC 2.2%

Value $3.403M Shares 798,718 Est. Cost $9.93 Unrealized -42.9%

RCKT ROCKET PHARMACEUTICALS INC 2.1%

Value $3.224M Shares 203,268 Est. Cost $23.61 Unrealized -26.8%

— QUIDEL CORP 1.9%

Value $2.887M Shares 25,675 Est. Cost $112.44 Unrealized —

EHC ENCOMPASS HEALTH CORP 1.8%

Value $2.837M Shares 39,900 Est. Cost $49.64 Unrealized +1.2%

OSCR OSCAR HEALTH INC 1.5%

Value $2.368M Shares 237,500 Est. Cost $14.31 Unrealized -48.0%

— ACCOLADE INC 1.4%

Value $2.184M Shares 124,393 Est. Cost $27.45 Unrealized —

SEM SELECT MED HLDGS CORP 1.4%

Value $2.178M Shares 90,788 Est. Cost $12.31 Unrealized 0.0%

CRSP CRISPR THERAPEUTICS AG 1.4%

Value $2.134M Shares 34,000 Est. Cost $75.34 Unrealized -16.7%

INMD INMODE LTD 1.2%

Value $1.846M Shares 50,000 Est. Cost $44.79 Unrealized 0.0%

MIRM MIRUM PHARMACEUTICALS INC 1.1%

Value $1.628M Shares 73,930 Est. Cost $20.40 Unrealized 0.0%

GMED GLOBUS MED INC 0.9%

Value $1.328M Shares 18,000 Est. Cost $72.59 Unrealized -4.2%

SPRY SILVERBACK THERAPEUTICS INC 0.7%

Value $1.142M Shares 325,365 Est. Cost $4.98 Unrealized -12.5%

NEO NEOGENOMICS INC 0.5%

Value $772K Shares 63,524 Est. Cost $21.04 Unrealized 0.0%

— ORGANON & CO 0.5%

Value $699K Shares 20,000 Est. Cost — Unrealized —

CGTX COGNITION THERAPEUTICS INC 0.4%

Value $660K Shares 240,080 Est. Cost $9.75 Unrealized -60.5%

PRQR PROQR THRAPEUTICS N V 0.3%

Value $542K Shares 599,288 Est. Cost $4.47 Unrealized -25.1%

— SIO GENE THERAPIES INC 0.3%

Value $449K Shares 670,300 Est. Cost $1.98 Unrealized —

IOVA IOVANCE BIOTHERAPEUTICS INC 0.2%

Value $333K Shares 20,000 Est. Cost $24.79 Unrealized -37.6%

— CYMABAY THERAPEUTICS INC 0.2%

Value $292K Shares 93,923 Est. Cost $3.38 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
GLPG	GALAPAGOS NV	374,000	$23.2M	15.0%	$58.55	—	SPON ADR	36315X101
PRTA	PROTHENA CORP PLC	566,538	$20.72M	13.4%	$26.31	+37.0%	SHS	G72800108
—	ALBIREO PHARMA INC	480,000	$14.32M	9.2%	$30.59	—	COM	01345P106
—	GALAPAGOS NV	195,000	$12.09M	7.8%	—	—	Call	36315X901
CRL	CHARLES RIV LABS INTL INC	31,500	$8.945M	5.8%	$347.75	-11.3%	COM	159864107
KALV	KALVISTA PHARMACEUTICALS INC	589,270	$8.686M	5.6%	$19.16	-25.0%	COM	483497103
CUE	CUE BIOPHARMA INC	1,510,282	$7.37M	4.8%	$11.54	-38.7%	COM	22978P106
ALDX	ALDEYRA THERAPEUTICS INC	1,400,239	$6.224M	4.0%	$7.18	-44.5%	COM	01438T106
MGTX	MEIRAGTX HLDGS PLC	380,700	$5.273M	3.4%	$15.40	0.0%	COM	G59665102
—	KEZAR LIFE SCIENCES INC	300,000	$4.986M	3.2%	$5.82	—	COM	49372L100
—	CONVEY HEALTH SOLUTIONS HLDG	748,134	$4.893M	3.2%	$9.97	—	COM	21258C108
ALNY	ALNYLAM PHARMACEUTICALS INC	22,704	$3.707M	2.4%	$185.86	-18.0%	COM	02043Q107
AGL	AGILON HEALTH INC	140,000	$3.549M	2.3%	$31.52	-34.6%	COM	00857U107
STTK	SHATTUCK LABS INC	798,718	$3.403M	2.2%	$9.93	-42.9%	COM	82024L103
RCKT	ROCKET PHARMACEUTICALS INC	203,268	$3.224M	2.1%	$23.61	-26.8%	COM	77313F106
—	QUIDEL CORP	25,675	$2.887M	1.9%	$112.44	—	COM	74838J101
EHC	ENCOMPASS HEALTH CORP	39,900	$2.837M	1.8%	$49.64	+1.2%	COM	29261A100
OSCR	OSCAR HEALTH INC	237,500	$2.368M	1.5%	$14.31	-48.0%	CL A	687793109
—	ACCOLADE INC	124,393	$2.184M	1.4%	$27.45	—	COM	00437E102
SEM	SELECT MED HLDGS CORP	90,788	$2.178M	1.4%	$12.31	0.0%	COM	81619Q105
CRSP	CRISPR THERAPEUTICS AG	34,000	$2.134M	1.4%	$75.34	-16.7%	NAMEN AKT	H17182108
INMD	INMODE LTD	50,000	$1.846M	1.2%	$44.79	0.0%	SHS	M5425M103
MIRM	MIRUM PHARMACEUTICALS INC	73,930	$1.628M	1.1%	$20.40	0.0%	COM	604749101
GMED	GLOBUS MED INC	18,000	$1.328M	0.9%	$72.59	-4.2%	CL A	379577208
SPRY	SILVERBACK THERAPEUTICS INC	325,365	$1.142M	0.7%	$4.98	-12.5%	COM	82835W108
NEO	NEOGENOMICS INC	63,524	$772K	0.5%	$21.04	0.0%	COM NEW	64049M209
—	ORGANON & CO	20,000	$699K	0.5%	—	—	Put	68622V956
CGTX	COGNITION THERAPEUTICS INC	240,080	$660K	0.4%	$9.75	-60.5%	COM	19243B102
PRQR	PROQR THRAPEUTICS N V	599,288	$542K	0.3%	$4.47	-25.1%	SHS EURO	N71542109
—	SIO GENE THERAPIES INC	670,300	$449K	0.3%	$1.98	—	COMMON	829399104
IOVA	IOVANCE BIOTHERAPEUTICS INC	20,000	$333K	0.2%	$24.79	-37.6%	COM	462260100
—	CYMABAY THERAPEUTICS INC	93,923	$292K	0.2%	$3.38	—	COM	23257D103